Bausch+Lomb News

1. Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents - AccessWire

   1. Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents  AccessWire
   2. Bausch Health and Bausch + Lomb's Ratings Unaffected by Unrestricting of Subsidiaries  Fitch Ratings
   3. Bausch Health calls Bausch + Lomb an unrestricted subsidiary (NYSE:BHC)  Seeking Alpha
   4. Bausch Health Announces the Unrestricting of Bausch + Lomb under Bausch Health Debt Covenants  Marketscreener.com
   5. View Full Coverage on Google News

2. Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs - PR Newswire

   Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs  PR Newswire

3. AAOpt 2022: Bausch + Lomb enters the canine healthcare landscape with new Project Watson - Optometry Times

   AAOpt 2022: Bausch + Lomb enters the canine healthcare landscape with new Project Watson  Optometry Times

4. RKS WINS MAJOR RULING: FRAUDULENT TRANSFER CLAIMS AGAINST BAUSCH HEALTH, BAUSCH + LOMB WILL MOVE FORWARD - Marketscreener.com

   RKS WINS MAJOR RULING: FRAUDULENT TRANSFER CLAIMS AGAINST BAUSCH HEALTH, BAUSCH + LOMB WILL MOVE FORWARD  Marketscreener.com

5. Bausch + Lomb's Biotrue Hydration Plus Multi-Purpose Solution Receives Award - Marketscreener.com

   Bausch + Lomb's Biotrue Hydration Plus Multi-Purpose Solution Receives Award  Marketscreener.com

6. Bausch + Lomb Third Quarter 2022 Earnings: EPS Misses Expectations - Simply Wall St

   Bausch + Lomb Third Quarter 2022 Earnings: EPS Misses Expectations  Simply Wall St

7. Baush + Lomb Uses LiveNX To Streamline Troubleshooting | Security News - SecurityInformed

   Baush + Lomb Uses LiveNX To Streamline Troubleshooting | Security News  SecurityInformed

8. Bausch + Lomb Corporation (BLCO) Q3 2022 Earnings Call Transcript - Seeking Alpha

   Bausch + Lomb Corporation (BLCO) Q3 2022 Earnings Call Transcript  Seeking Alpha

9. Pediatric Vitrectomy Market Future Business Opportunities 2022-2028 | Bausch + Lomb, Carl Zeiss Meditec AG, Optos Plc, Alcon, Orion Medic - Digital Journal

   Pediatric Vitrectomy Market Future Business Opportunities 2022-2028 | Bausch + Lomb, Carl Zeiss Meditec AG, Optos Plc, Alcon, Orion Medic  Digital Journal

10. What 7 Analyst Ratings Have To Say About Bausch & Lomb - Bausch & Lomb (NYSE:BLCO) - Benzinga

    What 7 Analyst Ratings Have To Say About Bausch & Lomb - Bausch & Lomb (NYSE:BLCO)  Benzinga

11. Bausch Health pulls plans for spinout of aesthetics device unit Solta Medical (NYSE:BHC) - Seeking Alpha

    Bausch Health pulls plans for spinout of aesthetics device unit Solta Medical (NYSE:BHC)  Seeking Alpha

12. Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs - PR Newswire

    Bausch + Lomb Introduces Project Watson™ Health Care Products for Dogs  PR Newswire

13. Bausch + Lomb, Sanoculis announce strategic agreements to address unmet needs in glaucoma - Ophthalmology Times

    Bausch + Lomb, Sanoculis announce strategic agreements to address unmet needs in glaucoma  Ophthalmology Times

14. Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments Intraocular Dyes - Vision Monday

    Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments Intraocular Dyes  Vision Monday

15. Bausch + Lomb Provides Leadership Update - PR Newswire

    Bausch + Lomb Provides Leadership Update  PR Newswire